NCT02019251View on ClinicalTrials.gov

Lung Transplant Subjects Using 19F MRI

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Post Single or Double Lung Transplant
Interventions
DRUG

perfluorinated gas/oxygen mixture

Subjects are imaged with MRI one time with the use of perfluorinated gas / oxygen mixtures as an MRI contrast agent for lung function.

DEVICE

MRI

Trial Locations (1)

27705

Duke University Medical Center, Durham

All Listed Sponsors
lead

Hal C Charles

OTHER

NCT02019251 - Lung Transplant Subjects Using 19F MRI | Biotech Hunter | Biotech Hunter